US Court to Weigh Obamacare Mandate to Cover HIV Drug, Cancer Screenings US Court to Weigh Obamacare Mandate to Cover HIV Drug, Cancer Screenings
President Joe Biden ' s administration on Monday is set to urge a U.S. appeals court to preserve a federal mandate that requires health insurers to cover preventive care...Reuters Health Information (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 4, 2024 Category: Cancer & Oncology Tags: Family Medicine/Primary Care Source Type: news
US Urges Court to Preserve Obamacare Mandate to Cover Cancer Screenings, HIV Drugs US Urges Court to Preserve Obamacare Mandate to Cover Cancer Screenings, HIV Drugs
President Joe Biden ' s administration on Monday urged a U.S. appeals court to preserve a federal mandate that requires health insurers to cover preventive care services...Reuters Health Information (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 4, 2024 Category: Cancer & Oncology Tags: Family Medicine/Primary Care Source Type: news
FDA Approves Amivantamab First-line Indication for NSCLC FDA Approves Amivantamab First-line Indication for NSCLC
Amivantamab plus carboplatin and pemetrexed is now available for first-line treatment of locally advanced or metastatic NSCLC with EGFR exon 20 insertion mutations.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 4, 2024 Category: Consumer Health News Tags: Hematology-Oncology Source Type: news
Fine Particulate Matter Affects EGFR-Mutated Lung Cancers Fine Particulate Matter Affects EGFR-Mutated Lung Cancers
Data suggest that patients with lung cancer who live in polluted areas have an additional 50% risk of carrying an oncogenic EGFR mutation.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 4, 2024 Category: Consumer Health News Tags: Hematology-Oncology Source Type: news
Outside the Guidelines: Denosumab Overuse in Prostate Cancer Outside the Guidelines: Denosumab Overuse in Prostate Cancer
Many men with castration-sensitive prostate cancer receive the bone-modifying agent to prevent skeletal-related events, but that practice is not recommended and costs Medicare millions annually.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 4, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
How Often Should Patients Receive Imaging After Spine SBRT? How Often Should Patients Receive Imaging After Spine SBRT?
A new study suggested a tailored MRI approach based on patients ' progression risk after stereotactic body radiotherapy for spinal metastases.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 4, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Taking Control of the Cancer Journey
(MedPage Today) -- "The Doctor's Art" is a weekly podcast that explores what makes medicine meaningful, featuring profiles and stories from clinicians, patients, educators, leaders, and others working in healthcare. Listen and subscribe/follow... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 3, 2024 Category: Hematology Source Type: news
Are Multitumor Blood Tests More Hype Than Help? Are Multitumor Blood Tests More Hype Than Help?
What the early cancer detection revolution means for you and your patients.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 1, 2024 Category: Consumer Health News Tags: Hematology-Oncology Expert Interview Source Type: news
Two Pembrolizumab Trials in Head and Neck Cancer Yield Divergent Results
(MedPage Today) -- Two first-line trials involving pembrolizumab (Keytruda)-based combinations for the treatment of recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) delivered mixed results.
While first-line pembrolizumab plus... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 1, 2024 Category: Hematology Source Type: news
New Tool Gauges Post –CAR T Relapse Risk in Multiple Myeloma New Tool Gauges Post –CAR T Relapse Risk in Multiple Myeloma
A simple prediction model developed with US and European cohorts effectively predicted relapse risk in multiple myeloma patients post anti-BCMA CAR-T therapy.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 1, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
New Drugs Yield Limited Benefit; Big Jump in Drug Prices; AI Boost for Mammo Results
(MedPage Today) -- Two-thirds of cancer drugs approved by the European Medicines Agency from 1995 to 2020 had little or no supporting evidence of added clinical benefit, particularly drugs that had fast-track designation. (The BMJ)
Meanwhile... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 1, 2024 Category: Hematology Source Type: news
What Do Oncology Patients Think of Electronic Monitoring? What Do Oncology Patients Think of Electronic Monitoring?
A survey indicates that patients are open to electronic monitoring systems, but the latter require dedicated personnel to implement.Medscape Medical News (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - March 1, 2024 Category: Primary Care Tags: Hematology-Oncology Source Type: news
Mental Health Issues Tied to Worse Cancer Surgery Outcomes Mental Health Issues Tied to Worse Cancer Surgery Outcomes
Cancer patients with behavioral health disorders are less likely to have surgery and face worse outcomes when they do, according to a new study.MDedge News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 1, 2024 Category: Consumer Health News Tags: Hematology-Oncology Source Type: news
Inadequate Knowledge: HPV and Oropharyngeal Carcinoma Inadequate Knowledge: HPV and Oropharyngeal Carcinoma
Dr Maurie Markman discusses a recent paper investigating knowledge about the relationship between HPV and oropharyngeal squamous cell carcinoma.Medscape Oncology (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - February 29, 2024 Category: Infectious Diseases Tags: Hematology-Oncology Commentary Source Type: news
Study Tests Office-Based Transperineal Approach to Prostate Biopsies
(MedPage Today) -- A multicenter randomized trial compared transperineal prostate biopsy without antibiotic prophylaxis versus transrectal biopsy with targeted prophylaxis, examining infections, prostate cancer detection, pain, and other measures... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - February 29, 2024 Category: Hematology Source Type: news
